These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Practical aspects of preventing and managing athersclerotic disease in post-menopausal women. Sullivan JM Eur Heart J; 1996 Aug; 17 Suppl D():32-7. PubMed ID: 8869880 [TBL] [Abstract][Full Text] [Related]
7. Postmenopausal hormone therapy and coronary heart disease in early postmenopausal women. Tuomikoski P; Mikkola TS Ann Med; 2014 Feb; 46(1):1-7. PubMed ID: 24266727 [TBL] [Abstract][Full Text] [Related]
8. Estrogens are indicated for the prevention of coronary artery disease: a debate for estrogen. Leiter LA Can J Cardiol; 2000 Aug; 16 Suppl E():13E-16E. PubMed ID: 10906619 [TBL] [Abstract][Full Text] [Related]
9. Risks of postmenopausal hormone replacement. Radford N; Church T JAMA; 2002 Dec; 288(22):2819; author reply 2823-4. PubMed ID: 12472311 [No Abstract] [Full Text] [Related]
11. Postmenopausal hormone therapy and the cardiovascular system. Speroff L; Lobo RA Heart Dis Stroke; 1994; 3(3):173-6. PubMed ID: 8044433 [No Abstract] [Full Text] [Related]
12. Estrogen replacement therapy and exercise performance in postmenopausal women with coronary artery disease. Collins P; Rosano G Am J Cardiol; 1998 Jan; 81(2):259-60. PubMed ID: 9591921 [No Abstract] [Full Text] [Related]
13. Estrogens should not be initiated for the secondary prevention of coronary artery disease: a debate. Hulley S Can J Cardiol; 2000 Aug; 16 Suppl E():10E-12E. PubMed ID: 10906618 [TBL] [Abstract][Full Text] [Related]
14. Low dose estrogens inhibit coronary artery atherosclerosis in postmenopausal monkeys. Appt SE; Clarkson TB; Lees CJ; Anthony MS Maturitas; 2006 Sep; 55(2):187-94. PubMed ID: 16574351 [TBL] [Abstract][Full Text] [Related]
17. [Further recognize the benefit and risk of postmenopausal hormone replacement therapy on atherosclerotic cardiovascular diseases]. Zhang Y Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):321-3. PubMed ID: 12947970 [No Abstract] [Full Text] [Related]
19. Women, hormones, and clinical trials: a beginning, not an end. Miller VM; Clarkson TB; Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Naftolin F; Santoro N J Appl Physiol (1985); 2005 Aug; 99(2):381-3. PubMed ID: 16020431 [No Abstract] [Full Text] [Related]
20. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study. Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]